Yong-Un Kim

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

Deepak L. Bhatt, R. Diaz, H. White, 2019, European heart journal.

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

Deepak L. Bhatt, A. Parkhomenko, R. Diaz, 2020, European heart journal.

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

Deepak L. Bhatt, R. Diaz, H. White, 2019, Circulation.

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome

Deepak L. Bhatt, R. Diaz, H. White, 2020, Circulation.

Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol

Deepak L. Bhatt, R. Diaz, H. White, 2021, Circulation.